In addition, Huangqi is capable of decreasing cardiac pressure load and volume load via vasodilation, which may result in slowing heart rate, reducing release kallikrein from central nervous system and renin angiotensin aldosterone system.[35–38] Theoretically, HI is a better option for treating CHF. Here, KLK4 is linked to congestive heart failure.